These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 17170524)

  • 1. Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonism.
    Rai A; Whaley-Connell A; McFarlane S; Sowers JR
    Am J Nephrol; 2006; 26(6):579-89. PubMed ID: 17170524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin dysregulation and hyponatremia in hospitalized patients.
    Multz AS
    J Intensive Care Med; 2007; 22(4):216-23. PubMed ID: 17712057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin dysregulation: hyponatremia, fluid retention and congestive heart failure.
    LeJemtel TH; Serrano C
    Int J Cardiol; 2007 Aug; 120(1):1-9. PubMed ID: 17346825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current treatments and novel pharmacologic treatments for hyponatremia in congestive heart failure.
    Goldsmith SR
    Am J Cardiol; 2005 May; 95(9A):14B-23B. PubMed ID: 15847853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin antagonists: role in the management of hyponatremia.
    Yeates KE; Morton AR
    Am J Nephrol; 2006; 26(4):348-55. PubMed ID: 16837788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological impact of vasopressin dysregulation and hyponatremia.
    Bhardwaj A
    Ann Neurol; 2006 Feb; 59(2):229-36. PubMed ID: 16437573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition and treatment of hyponatremia in acutely ill hospitalized patients.
    Patel GP; Balk RA
    Clin Ther; 2007 Feb; 29(2):211-29. PubMed ID: 17472815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin excess and hyponatremia.
    Pham PC; Pham PM; Pham PT
    Am J Kidney Dis; 2006 May; 47(5):727-37. PubMed ID: 16632011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.
    Wong F; Blei AT; Blendis LM; Thuluvath PJ
    Hepatology; 2003 Jan; 37(1):182-91. PubMed ID: 12500203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyponatremia and arginine vasopressin dysregulation: mechanisms, clinical consequences, and management.
    Miller M
    J Am Geriatr Soc; 2006 Feb; 54(2):345-53. PubMed ID: 16460390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyponatremia in heart failure: the role of arginine vasopressin and its antagonism.
    Rosner MH; Ronco C
    Congest Heart Fail; 2010 Jul; 16 Suppl 1():S7-14. PubMed ID: 20653716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment options for hyponatremia in heart failure.
    Goldsmith SR
    Congest Heart Fail; 2010 Jul; 16 Suppl 1():S15-8. PubMed ID: 20653706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of arginine vasopressin receptor antagonists in hyponatremia in the elderly.
    Miller M
    Geriatrics; 2007 Jul; 62(7):20-6. PubMed ID: 17620018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolvaptan, an orally active vasopressin V(2)-receptor antagonist - pharmacology and clinical trials.
    Miyazaki T; Fujiki H; Yamamura Y; Nakamura S; Mori T
    Cardiovasc Drug Rev; 2007; 25(1):1-13. PubMed ID: 17445084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms, risks, and new treatment options for hyponatremia.
    Ghali JK
    Cardiology; 2008; 111(3):147-57. PubMed ID: 18434717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyponatremia in heart failure.
    Chatterjee K
    J Intensive Care Med; 2009; 24(6):347-51. PubMed ID: 19850560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.
    Decaux G
    J Lab Clin Med; 2001 Jul; 138(1):18-21. PubMed ID: 11433224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management.
    Ginès P; Guevara M
    Hepatology; 2008 Sep; 48(3):1002-10. PubMed ID: 18671303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
    Palm C; Pistrosch F; Herbrig K; Gross P
    Am J Med; 2006 Jul; 119(7 Suppl 1):S87-92. PubMed ID: 16843091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin receptor antagonists: potential indications and clinical results.
    Arai Y; Fujimori A; Sudoh K; Sasamata M
    Curr Opin Pharmacol; 2007 Apr; 7(2):124-9. PubMed ID: 17292670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.